Targeted vs. General Antiparasitic Treatment for High Eosinophils
Treatments studied
Part of Blood & lymphatic clinical trials.
This study compares a specific antiparasitic treatment to a general one for people with high eosinophil levels (a type of white blood cell). If you have eosinophilia without an obvious cause, you may be assigned to receive either a targeted drug or a broader treatment to see which works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your blood test shows a high level of eosinophils (over 500) but your white blood cells are not too high (under 10,000).
- You are at least 18 years old and willing to participate.
- You have not taken any parasite-killing drugs in the last 6 months.
- You do not have active cancer, HIV, hepatitis, or other serious infections.
- You have not recently taken certain medications that can raise eosinophil levels (like some pain relievers or herbal supplements).
- You are not pregnant, breastfeeding, or allergic to albendazole, ivermectin, or metronidazole.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study examines how eosinophils (a type of white blood cell) behave and function when they become abnormally high in the blood or tissues. Researchers want to understand these conditions better to potentially improve treatment options.
This study follows people with long-term high eosinophils (a type of white blood cell) and related conditions to learn how the illness changes over time. It helps doctors understand patterns of organ involvement and outcomes, which may improve future care.
This study follows families with a genetic condition that causes high levels of white blood cells called eosinophils. Researchers want to understand how the disease develops and changes over time to help predict who may get worse and how to treat it better.
This trial studies different types of eosinophil cells in people with asthma, eosinophilic granulomatosis with polyangiitis (EGPA), or hypereosinophilic syndrome (HES). It also includes healthy volunteers. The goal is to better understand these cells in each condition.
This study looks at how certain immune cells (eosinophils) work in people with asthma. It compares people with mild to severe asthma, including those who have or haven't taken biologic treatments, against people without asthma. The goal is to better understand asthma and find new ways to treat it.
This study looks at how eosinophilic inflammation in the esophagus and intestines affects outcomes like symptoms and test findings. It may help clinicians better understand these conditions and track what changes over time.
Hear when a new Eosinophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.